Livforsakringsbolaget Skandia, Omsesidigt Regeneron Pharmaceuticals, Inc. Put Options Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.72 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding REGN
# of Institutions
1,512Shares Held
82.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.41 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.81 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.15 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.37 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.96 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...